| Name |
Norditropin NordiFlex 15 mg/1,5 ml otopina za injekciju u napunjenoj brizgalici |
| Marketing Authorisation Number |
HR-H-316996287 |
| Active Substance |
somatropin |
| Composition |
jedan ml otopine sadrži 10 mg somatropina |
| Pharmaceutical Form |
otopina za injekciju u napunjenoj brizgalici |
| Manufacturer |
Novo Nordisk A/S, Bagsvaerd, Danska |
| Marketing Authorisation Holder |
Novo Nordisk A/S, Novo Alle, Bagsvaerd, Danska |
| Marketing Authorisation Date |
08.10.2024 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/23-02/126 |
| Registration Number |
381-12-01/70-24-04 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
ograničeni recept
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
H01AC01 |
| Marketing status |
trajni prekid opskrbe |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
